A message from our partners at Huge Alerts 
BSEM Just Released Publication of Its Audited Financial Statements for Fiscal Years 2024 and 2025—Fast-Tracking a High-Profile Nasdaq Uplisting! BioStem Technologies (OTCQB: BSEM) is rapidly evolving from a niche regenerative medicine innovator into a full-scale MedTech growth story. The company’s recent acquisition of BioTissue Holdings’ surgical and wound care business for up to $40 million not only broadens its market from physician offices into hospitals and surgical centers but also immediately adds $29 million in revenue and a seasoned national sales team. Coupled with the proven BioREtain® technology and breakthrough clinical results demonstrating superior wound closure rates, BSEM is now uniquely positioned to address a $300–$350 million total addressable market. On the financial front, BSEM continues to impress. Q4 revenue topped $10 million with nearly best-in-class gross margins of 97%, and adjusted EBITDA remained solid at $3.4 million despite temporary headwinds. Importantly, the company has published its audited 2024–2025 financials, a key milestone toward its highly anticipated Nasdaq uplisting in 2026. This move promises increased liquidity, institutional investor interest, and higher valuation potential. With analysts assigning a $25.50 price target, BSEM’s combination of earnings strength, strategic expansion, and regulatory readiness underscores a rare small-cap investment story with multiple growth levers. BioStem just hit a critical milestone with its audited financials. See how this could set the stage for a NASDAQ uplisting soon!
This Month's Featured Article Is 2026 the Year of Space Stocks? 2 Stocks to WatchAuthored by Ryan Hasson. Published: 3/25/2026. 
Key Points - The potential SpaceX IPO has put the space sector in the spotlight, but Rocket Lab and Planet Labs are already delivering exceptional returns with or without it.
- Rocket Lab completed 21 successful launches in 2025, achieving a 100% mission success rate, and grew its backlog to $1.85 billion.
- Planet Labs just reported record revenue, reached adjusted EBITDA profitability for the first time, and saw several analysts raise price targets to $40.
- Special Report: Do this before SpaceX IPOs or be sorry
 The space sector may be on the verge of its biggest moment yet. Reports and rumors are circulating that SpaceX, the world's largest space company, could announce its long-awaited IPO as early as mid-2026, with early estimates placing its valuation near $1.5 trillion. If that materializes, it would rank among the largest IPOs in history and could lift the entire aerospace sector. But even before SpaceX trades publicly, the space sector is already having a standout year. Rocket Lab (NASDAQ: RKLB) is up about 230% over the past year. Planet Labs (NYSE: PL) has surged more than 700% over the same period and is up a remarkable 65% year to date. With a rising defense budget, a potential landmark IPO on the horizon, and several sector names already delivering exceptional returns, 2026 is shaping up to be a defining year for space stocks. Here are two to watch closely. Rocket Lab: Building the Infrastructure of the Space Economy Rocket Lab is an end-to-end aerospace company that provides launch services, spacecraft and space systems to commercial and government customers. Its primary launch vehicle, the Electron rocket, is a small-lift orbital vehicle designed to deploy satellites and rideshare payloads to low Earth orbit. With more than 250 launches and over 1,700 satellites in orbit carrying Rocket Lab technology, Electron has established itself as one of the most reliable and frequently flown small-lift rockets in the market. Its most anticipated catalyst is Neutron, a medium-lift rocket intended to compete directly with SpaceX's Falcon 9. Built for mega-constellation deployment and deep-space missions, Neutron will carry payloads up to 13,000 kilograms, substantially expanding Rocket Lab's addressable market. The fundamentals for Rocket Lab continue to impress. In Q4 2025, Rocket Lab reported EPS of negative $0.03, beating the consensus estimate of negative $0.05, with quarterly revenue rising 48% year over year to $155.08 million. The company closed out 2025 with a record 21 successful launches, a 100% mission success rate, and a backlog that climbed 73% to $1.85 billion. Roughly 37% of that backlog is expected to convert to revenue within the next 12 months, providing strong forward visibility. Analysts maintain a consensus Moderate Buy rating, with a price target implying more than 15% additional upside from current levels. Planet Labs: Record Revenue and a Breakout Quarter Planet Labs was founded with a bold mission: to image the entire Earth every day and make that data visible, accessible and actionable. The company operates one of the largest fleets of Earth-imaging satellites, delivering high-frequency, high-resolution imagery and analytics to customers across government, agriculture, energy and finance. That mission is translating into accelerating financial results. In its most recent quarter, Planet Labs reported revenue of $86.8 million, up 41% year over year — a new quarterly record. Full-year revenue for the fiscal period ending 2026 rose 26% to $307.7 million, also a record. Perhaps most significantly, the company achieved adjusted EBITDA profitability for the first time in a fiscal year and generated positive free cash flow, two milestones that mark a meaningful inflection point in the business. Backlog climbed 79% year over year to $900 million, driven by strong government demand, new satellite launches and expanding partnerships. Looking ahead, management guided fiscal 2027 revenue of $415 million to $440 million. Institutions have been active buyers, with $693 million in inflows over the prior 12 months versus $308 million in outflows. Following the results, analysts at Cantor Fitzgerald, Wedbush and Needham raised their price targets to $40, implying nearly 47% upside at the time of the report. With a potential SpaceX IPO on the horizon and sector momentum already building, both Rocket Lab and Planet Labs are worth keeping on your radar. | 
0 Response to "BSEM Prepares for Nasdaq: What Investors Need to Know!!"
Post a Comment